Brain_Navi_Biotechnology unveils NaoTrac neurosurgical robot

Brain Navi Biotechnology>>> has developed NaoTrac>>>, a neurosurgical navigational robot designed to revolutionize brain surgery. This technology enhances precision, reduces surgical time from 49.1 minutes to 2.4 minutes, and simplifies the learning curve for surgeons by utilizing machine vision and 3D positioning to detect facial checkpoints without invasive head frames. NaoTrac>>> operates with a 'semi-autonomous' model, ensuring stability and precision while allowing surgeons to maintain professional judgment. The system has received global approvals from regulatory bodies like TFDA, CE, United States — Food and Drug Administration>>>, and India — Central Drugs Standard Control Organisation>>>, underscoring its world-class quality. Dr. Jerry Chieh Hsiao Chen, CEO of Brain Navi Biotechnology>>>, spearheaded this innovation, aiming to make surgery more precise and improve patient lives. The technology represents a significant advancement in minimally invasive neurosurgery, transforming Taiwanese ingenuity into a global force for health.